Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 16;21(1):1115.
doi: 10.4102/sajhivmed.v21i1.1115. eCollection 2020.

Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update

Affiliations

Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update

Jeremy Nel et al. South Afr J HIV Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

FIGURE 1
FIGURE 1
Timing of viral load monitoring of the patient starting antiretroviral therapy. For patients with a viral load > 50 copies/mL on two consecutive occasions, refer to the text.
FIGURE 2
FIGURE 2
Suggested approach to patients with low cluster of differentiation 4 counts despite a suppressed viral load on antiretroviral therapy.
FIGURE 3
FIGURE 3
Switching from a first-line non-nucleoside reverse transcriptase inhibitor-based regimen to a dolutegravir-based regimen.
FIGURE 4
FIGURE 4
Virological monitoring of patients receiving dolutegravir-based first-line antiretroviral therapy and response to results.
FIGURE 5
FIGURE 5
Indications for performing resistance (genotype) testing in second-line antiretroviral therapy.

References

    1. Johnson LF, Mossong J, Dorrington RE, et al. . Life expectancies of South African adults starting antiretroviral treatment: Collaborative analysis of cohort studies. PLoS Med. 2013;10(4):e1001418 10.1371/journal.pmed.1001418 - DOI - PMC - PubMed
    1. Maartens G. ‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy. S Afr J HIV Med. 2020;21(1):a1036 10.4102/sajhivmed.v21i1.1036 - DOI - PMC - PubMed
    1. Benhamou Y, Bochet M, Thibault V, et al. . Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology. 1999;30(5):1302–1306. 10.1002/hep.510300525 - DOI - PubMed
    1. Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, et al. . Tenofovir nephrotoxicity: 2011 update. AIDS Res Treat. 2011;2011:354908 10.1155/2011/354908 - DOI - PMC - PubMed
    1. Venter WDF, Fabian J, Feldman C. An overview of tenofovir and renal disease for the HIV-treating clinician. South Afr J HIV Med. 2018;19(1):817 10.4102/sajhivmed.v19i1.817 - DOI - PMC - PubMed

LinkOut - more resources